Shen L - Search Results

1

Early change in peripheral CD4⁺ T cells associated with clinical outcomes of immunotherapy in gastrointestinal cancer.

Liu C, Wang Y, Li S, Jiao X, Zou J, Wang Z, Qi C, Zhang X, Li J, Lu Z, Shen L. Liu C, et al. Among authors: shen l. Immunotherapy. 2021 Jan;13(1):55-66. doi: 10.2217/imt-2020-0068. Epub 2020 Oct 22. Immunotherapy. 2021. PMID: 33086925

2

[Application of sandostatin in malignant bowel obstruction].

Li J, Jing ML, Shen L. Li J, et al. Among authors: shen l. Zhonghua Wei Chang Wai Ke Za Zhi. 2007 Sep;10(5):479-81. Zhonghua Wei Chang Wai Ke Za Zhi. 2007. PMID: 17851794 Chinese.

3

[Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma].

Zhang XD, Shen L, Li J, Li Y, Li J, Zhang XT, Jin ML. Zhang XD, et al. Among authors: shen l. Zhonghua Zhong Liu Za Zhi. 2007 Jun;29(6):474-7. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 17974288 Clinical Trial. Chinese.

4

A phase II trial of paclitaxel and cisplatin in patients with advanced squamous-cell carcinoma of the esophagus.

Zhang X, Shen L, Li J, Li Y, Li J, Jin M. Zhang X, et al. Among authors: shen l. Am J Clin Oncol. 2008 Feb;31(1):29-33. doi: 10.1097/COC.0b013e3181131ca9. Am J Clin Oncol. 2008. PMID: 18376224 Clinical Trial.

5

[Polymorphisms of UGT1A gene and irinotecan toxicity in Chinese colorectal cancer patients].

Wang Y, Xu JM, Shen L, Xu N, Wang JW, Jiao SC, Zhang JS, Song ST, Li J, Bao HY, Yang L, Li F. Wang Y, et al. Among authors: shen l. Zhonghua Zhong Liu Za Zhi. 2007 Dec;29(12):913-6. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 18478930 Chinese.

6

[Irinotecan plus fuorouracil/leucovorin (FOLFIRI) as a second line chemotherapy for refractory or metastatic colorectal cancer].

Li J, Xu JM, Li J, Zhang XD, Bai Y, Chu YP, Wang YH, Liu DQ, Jin ML, Shen L. Li J, et al. Among authors: shen l. Zhonghua Zhong Liu Za Zhi. 2008 Mar;30(3):225-7. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 18756942 Clinical Trial. Chinese.

7

[Cetuximab in combination with chemotherapy for patients with gastrointestinal cancer].

Zhang XT, Shen L, Zhang XD, Li J, Zhang ZT. Zhang XT, et al. Among authors: shen l. Zhonghua Zhong Liu Za Zhi. 2008 May;30(5):385-8. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 18953842 Chinese.

8

[Association of CT image changes and prognosis in gastrointestinal stromal tumor after targeted therapy].

Tang L, Sun YS, Shen L, Li J, Cao K, Qi LP, Cui Y, Zhang XP. Tang L, et al. Among authors: shen l. Zhonghua Wei Chang Wai Ke Za Zhi. 2010 Jul;13(7):497-501. Zhonghua Wei Chang Wai Ke Za Zhi. 2010. PMID: 20658362 Chinese.

9

Gastrointestinal stromal tumors treated with imatinib mesylate: apparent diffusion coefficient in the evaluation of therapy response in patients.

Tang L, Zhang XP, Sun YS, Shen L, Li J, Qi LP, Cui Y. Tang L, et al. Among authors: shen l. Radiology. 2011 Mar;258(3):729-38. doi: 10.1148/radiol.10100402. Epub 2010 Dec 30. Radiology. 2011. PMID: 21193597

10

Efficacy of imatinib dose escalation in Chinese gastrointestinal stromal tumor patients.

Li J, Gong JF, Li J, Gao J, Sun NP, Shen L. Li J, et al. Among authors: shen l. World J Gastroenterol. 2012 Feb 21;18(7):698-703. doi: 10.3748/wjg.v18.i7.698. World J Gastroenterol. 2012. PMID: 22363143 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,562 results

Search Page

Filters